Pharmacogenomics of human OATP transporters

Naunyn-Schmiedeberg's Archives of Pharmacology
Jörg KönigMartin F Fromm

Abstract

Organic anion transporting polypeptides (OATPs) mediate the uptake of a broad range of compounds into cells. Substrates for members of the OATP family include bile salts, hormones, and steroid conjugates as well as drugs like the HMG-CoA-reductase inhibitors (statins), cardiac glycosides, anticancer agents like methotrexate, and antibiotics like rifampicin. OATPs are expressed in a variety of different tissues, including intestine, liver, kidney, and brain, suggesting that they play a critical role in drug absorption, distribution, and excretion. The identification and functional characterisation of naturally occurring variations in genes encoding human OATP (SLCO) family members is in the focus of transporter research. As a result of their broad substrate spectrum and their wide tissue distribution, altered transport characteristics or protein localisation can contribute significantly to interindividual variations of drug effects. The analysis of the consequences of genetic variations in genes encoding transport proteins may, therefore, contribute to a better understanding of interindividual differences in drug effects and to individualise treatment regimens with drugs that are substrates for human OATP proteins. In this revie...Continue Reading

References

Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·E JacqueminP J Meier
Oct 27, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G A Kullak-UblickG Paumgartner
Dec 16, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P J MeierB Stieger
Apr 29, 1998·Clinical Pharmacology and Therapeutics·P J NeuvonenK T Kivistö
Jan 27, 1999·Biochemical and Biophysical Research Communications·E C FriesemaT J Visser
Apr 20, 1999·Biochemical and Biophysical Research Communications·L PascoloC Tiribelli
Jan 25, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·J KönigD Keppler
Apr 26, 2000·The Journal of Biological Chemistry·J KönigD Keppler
Jun 30, 2000·Biochemical and Biophysical Research Communications·I TamaiA Tsuji
Jan 13, 2001·The Journal of Biological Chemistry·Y CuiD Keppler
Jun 5, 2002·Annual Review of Biochemistry·P Borst, R Oude Elferink
Jun 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stephan R VavrickaKarin Fattinger
Dec 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Rommel G TironaRichard B Kim
Jan 1, 2003·Biochimica Et Biophysica Acta·B Hagenbuch, P J Meier
May 2, 2003·The Journal of Pharmacology and Experimental Therapeutics·Daisuke KobayashiIkumi Tamai
Jun 18, 2003·Clinical Pharmacology and Therapeutics·Yohei NishizatoYuichi Sugiyama
Oct 8, 2003·Naunyn-Schmiedeberg's Archives of Pharmacology·Thomas FehrenbachDietrich Keppler
Oct 25, 2003·Oncogene·Gary D Kruh, Martin G Belinsky
Nov 12, 2003·The Journal of Pharmacology and Experimental Therapeutics·Takashi NozawaIkumi Tamai
Nov 19, 2003·Pflügers Archiv : European journal of physiology·Matthias A HedigerElspeth A Bruford
Feb 24, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Takashi NozawaIkumi Tamai
Mar 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Tsuyoshi MikkaichiTakaaki Abe
Apr 30, 2004·Clinical Pharmacology and Therapeutics·Jessica MwinyiThomas Gerloff
Apr 30, 2004·Clinical Pharmacology and Therapeutics·Dennis W SchneckAli Raza
May 26, 2004·The Journal of Pharmacology and Experimental Therapeutics·Masaru HiranoYuichi Sugiyama
Jul 9, 2004·Biochimica Et Biophysica Acta·Fabienne Meier-AbtBruno Hagenbuch

❮ Previous
Next ❯

Citations

Mar 15, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Ernst Petzinger, Joachim Geyer
Mar 11, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Ernst PetzingerRobert Tampé
Nov 9, 2007·Molecular Genetics and Genomics : MGG·Annick SeithelJörg König
Sep 29, 2012·Molecular Diagnosis & Therapy·Gaia Chiara Mannino, Giorgio Sesti
Sep 21, 2012·Chemical Research in Toxicology·M CalatayudV Devesa
Mar 1, 2008·Nature Reviews. Drug Discovery·Paul D Dobson, Douglas B Kell
Apr 2, 2010·Molecular BioSystems·Alexandra G IanculescuThomas S Scanlan
Jul 25, 2008·The New England Journal of Medicine·UNKNOWN SEARCH Collaborative GroupR Collins
Aug 22, 2012·Human Molecular Genetics·Chun-Yu WeiYuan-Tsong Chen
Feb 26, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Hong LuCurtis D Klaassen
Oct 24, 2008·Current Opinion in Rheumatology·Georgirene D Vladutiu
Jun 14, 2008·Pharmacogenetics and Genomics·Stefan OswaldWerner Siegmund
Sep 11, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tian LanPaul A Dawson
Aug 19, 2011·The Journal of Pharmacology and Experimental Therapeutics·Yuling ChiVictor L Schuster
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Akinobu HamadaWilliam D Figg
Jun 22, 2011·Digestive Diseases·Ralf KubitzDieter Häussinger
Jan 11, 2012·The Journal of Clinical Investigation·Evita van de SteegAlfred H Schinkel
Aug 13, 2011·Thyroid Research·Anita KinneGerd Krause
May 25, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ming YangPhilip W Kantoff
Dec 3, 2009·Biological & Pharmaceutical Bulletin·Eva BrcakovaStanislav Micuda
May 18, 2010·Environmental Health Perspectives·Daniel FeursteinDaniel R Dietrich
Sep 19, 2012·Drug Metabolism and Pharmacokinetics·Masahiro SegawaKen Iseki
Nov 15, 2012·Drug Metabolism and Pharmacokinetics·Andrée-Anne BoivinMichel Roger
Jan 1, 2011·Pharmacogenomics and Personalized Medicine·Jing Li, Martin H Bluth
Jun 28, 2011·AJR. American Journal of Roentgenology·Takashi KumadaTeruyoshi Ishikawa
May 31, 2011·Pharmacogenomics·Bruno Stieger, Peter J Meier
Apr 23, 2010·Marine Drugs·Ioannis SainisEvangelos Briasoulis
Feb 5, 2008·Pharmacogenomics·Mikko Niemi
Apr 3, 2014·Cell & Bioscience·Delira Robbins, Taosheng Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2021 Meta ULC. All rights reserved